Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on May 13, 2025
Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update
GlobeNewswire
·
May 13, 2025
Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative …
Caliber Hospitality Development Launches to Pursue Opportunistic and Distressed Hotel Investments
GlobeNewswire
·
May 13, 2025
SCOTTSDALE, Ariz., May 13, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, today announced the launch of Caliber Hospitality Development, LLC (“CHD”), a joint venture between Caliber and GIA Hospitality, LLC …
Knight to Present at the 2025 RBC Capital Markets Global Healthcare Conference in New York City
GlobeNewswire
·
May 13, 2025
MONTREAL, May 13, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to participate in a …
MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers
GlobeNewswire
·
May 13, 2025
YAVNE, Israel, May 13, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced the publication of a peer-reviewed post hoc analysis in Wounds. The analysis is …
First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study
GlobeNewswire
·
May 13, 2025
- ATTRibute-CM, BridgeBio’s Phase 3 clinical trial of acoramidis in patients with ATTR-CM, achieved statistical significance in reducing the risk of ACM or first CVH versus placebo in ATTRv-CM patients (59.1% risk reduction), establishing the mechanistic …
Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference
GlobeNewswire
·
May 13, 2025
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, …
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%
GlobeNewswire
·
May 13, 2025
Filed 510(k)Submission with FDA for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain Ahead of Schedule Company Fully Funded Through at Least Fiscal Year 2026 Following Oversubscribed $8.2 Million Capital Raise EDEN PRAIRIE, Minn., May 13, 2025 …
Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 13, 2025
- Commenced market launch and first commercial sales of Symvess™ (acellular tissue engineered vessel-tyod) for the treatment of extremity vascular trauma - - Total revenues of $517,000 for quarter from sales and collaborative research agreement – - …
Atomic Minerals Announces Share Exchange Agreement to Acquire Quebec Mineral Claims
GlobeNewswire
·
May 13, 2025
Vancouver, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Atomic Minerals Corporation ("Atomic Minerals" or the "Company") (TSX Venture: ATOM) is pleased to announce that it has entered into a share exchange agreement (the “Agreement”) with the …
Knight présentera à la conférence sur la santé internationale de 2025 de RBC Marchés des Capitaux à New York
GlobeNewswire
·
May 13, 2025
MONTRÉAL, 13 mai 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (ex-ÉU), a annoncé aujourd'hui que Samira Sakhia, présidente et chef de la direction, participera à une …
American Tungsten Corp. To Host Management Update Webinar
GlobeNewswire
·
May 13, 2025
Vancouver, BC, May 13, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) announces that the Company’s CEO, Ali Haji will host a webinar to give an overview of the company’s recent …
Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program
GlobeNewswire
·
May 13, 2025
Reiterates Planned Submission of an NDA for Cytisinicline to FDA in June 2025 Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, May 13, 2025 SEATTLE and VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. …
XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements
GlobeNewswire
·
May 13, 2025
Pipeline advancements: The Marketing Authorization Application (MAA) for Day One Biopharmaceuticals and Ipsen’s tovorafenib was accepted for review by the European Marketing Authority (EMA) and Takeda initiated its Phase 3 trial exploring mezagitamab for …
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
May 13, 2025
BURLINGTON, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today reported business updates …
Stardust Power Confirms No Industrial Wastewater Permit Required for Oklahoma Lithium Facility
GlobeNewswire
·
May 13, 2025
GREENWICH, Conn., May 13, 2025 (GLOBE NEWSWIRE) -- Stardust Power Inc. ("Stardust Power" or the "Company"), an American developer of battery-grade lithium products, today announced a significant update to its permitting process. Following a determination …
Cytokinetics Announces Positive Topline Results From MAPLE-HCM
GlobeNewswire
·
May 13, 2025
Trial Demonstrates Superiority of Aficamten to Standard of Care Beta Blocker in Improving Peak Exercise Capacity in Patients with Obstructive Hypertrophic Cardiomyopathy SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, …
Prime Biome Reviews (Consumer Report 2025): The Gut Health and Skin Supplement That’s Getting Noticed
GlobeNewswire
·
May 13, 2025
SAN JOSE, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- I’ll be honest—I've tried more probiotics than I can count. From popular capsules at local stores to trendy gummies delivered from across the country, none of them lived up to the hype. Some offered short- …
Purple Pepe listed on major crypto exchanges, enters US real estate market
GlobeNewswire
·
May 13, 2025
WEST PALM BEACH, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- The viral crypto project Purple Pepe (PURPE) continues its rise with multiple new exchange listings and a historic leap into real-world utility. Less than a year since its launch, the community-driven …
AquaSculpt Reviews and Complaints: Is Aqua Sculpt’s Top Weight Loss Secrets Too Good to Believe? (Shocking Results!)
GlobeNewswire
·
May 13, 2025
AUSTIN, Texas, May 13, 2025 (GLOBE NEWSWIRE) -- AquaSculpt is among the most often discussed natural supplements for weight loss in 2025—and it's not hard to understand why. Search engines with searches like "Aqua Sculpt Pills," "Aqua Sculpt Weight Loss …
Best Online Casino Bonus: Latest Promo Codes 2025 – Get Free Spins & Welcome Bonuses! – By 7Bit Casino
GlobeNewswire
·
May 13, 2025
OKLAHOMA CITY, May 13, 2025 (GLOBE NEWSWIRE) -- 7Bit Casino has earned its place among the top-rated real money online casinos in 2025. In a rapidly evolving iGaming world, it stands out with its seamless crypto integration and generous no-deposit bonuses, …